CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | Satter Muneer A Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-06-08 | WIGGANS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-06-08 | Choi Jung Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-06-08 | Cockroft Bettina M. Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-06-08 | Waddill William D. Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-06-08 | Carson William H. Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-05-25 | Bain Capital Life Sciences Investors, LLC 10% owner | Purchase | +300,000 | $2.13 | $640K | 5,701,926 |
| 2023-02-16 | Love Douglas President & CEO | Grant or award · Stock Option (Right to Buy) | +345,000 | 345,000 | ||
| 2023-02-16 | Overdorf Michael EVP & Chief Business Officer | Grant or award | +18,975 | 46,780 | ||
| 2023-02-16 | Overdorf Michael EVP & Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +77,050 | 77,050 | ||
| 2023-02-16 | Lew Jennifer EVP & Chief Financial Officer | Grant or award | +18,975 | 48,517 | ||
| 2023-02-16 | Lew Jennifer EVP & Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +77,050 | 77,050 | ||
| 2023-02-15 | Love Douglas President & CEO | Sale | −6,571 | $5.87 | $39K | 197,646 |
| 2023-02-14 | Overdorf Michael EVP & Chief Business Officer | Sale | −144 | $6.30 | $907 | 27,805 |
| 2023-02-14 | Lew Jennifer EVP & Chief Financial Officer | Sale | −166 | $6.30 | $1K | 29,542 |
| 2023-02-13 | Overdorf Michael EVP & Chief Business Officer | Sale | −1,501 | $6.30 | $9K | 27,949 |
| 2023-02-13 | Lew Jennifer EVP & Chief Financial Officer | Sale | −1,742 | $6.31 | $11K | 29,708 |
| 2023-02-10 | Satter Muneer A Director | Purchase | +2,647,058 | $6.80 | $18.0M | 7,056,024 |
| 2023-01-15 | ARTIS DEAN RICHARD EVP & Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2022-07-11 | Overdorf Michael EVP & Chief Business Officer | Grant or award | +9,375 | 21,875 |
Page 8 of 15 · 292 trades